Generalized obesity has been associated with cognitive decline, a process potentially mediated by adipocytokines. The effects of regional adipose tissue (AT) on cognition, however, are not well understood. We explored cross-sectional relationships between regional AT, adipocytokines, inflammatory markers and neuropsychological (NP) test scores among HIV+ and HIV- men enrolled in the Multicenter AIDS Cohort Study.
Methods
Visceral, subcutaneous abdominal and subcutaneous thigh AT areas were quantified by computed tomography (CT). NP tests (Trail Making Test parts A and B, and Symbol-Digit Modalities) obtained within 2 years of CT screened for psychomotor speed and executive function. Adiponectin, leptin, interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) were measured.
Results
Of 509 HIV+ and 271 HIV- participants, HIV+ men (98% on antiretroviral therapy, 81% HIV-1 RNA<50 copies/ml) had lower median subcutaneous AT and adiponectin levels and higher hs-CRP levels, but visceral AT, body mass index, IL-6 and NP scores did not vary by HIV serostatus. In multivariable analysis, older age, ≤ high school education and African American race, but not AT area or site, were associated with worse NP test scores among all participants. In HIV+ only, higher adiponectin and IL-6 were associated with worse cognitive function independent of AT area. No HIV-specific factors were associated with NP test scores.
Conclusions
Demographic factors were associated with NP test performance, but regional adiposity was not. In HIV+ only, higher adiponectin and IL-6 were associated with worse NP test scores, supporting a role for chronic inflammation and adipocytokine imbalance in neurocognitive decline in HIV+ persons.
References
1.
HadiganC., MeigsJ.B., WilsonP.W.Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.Clin Infect Dis2003; 36: 909–916.
2.
CurrierJ., ScherzerR., BacchettiP.Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women.J Acquir Immune Defic Syndr2008; 48: 35–43.
3.
WohlD., ScherzerR., HeymsfieldS.The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.J Acquir Immune Defic Syndr2008; 48: 44–52.
4.
LakeJ.E., WohlD., ScherzerR.Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.AIDS Care2011; 23: 929–938.
5.
DolanS.E., HadiganC., KillileaK.M.Increased cardiovascular disease risk indices in HIV-infected women.J Acquir Immune Defic Syndr2005; 39: 44–54.
6.
FujiokaS., MatsuzawaY., TokunagaK., TaruiS.Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.Metabolism1987; 36: 54–59.
7.
GrunfeldC., RimlandD., GibertC.L.Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.J Acquir Immune Defic Syndr2007; 46: 283–290.
8.
KanayaA.M., LindquistK., HarrisT.B.Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study.Arch Neurol2009; 66: 329–335.
9.
WestN.A., HaanM.N.Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study.J Gerontol A Biol Sci Med Sci2009; 64: 103–109.
10.
McCutchanJ.A., Marquie-BeckJ.A., FitzsimonsC.A.Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.Neurology2012; 78: 485–492.
11.
CrawfordK.W., LiX., XuX.Lipodystrophy and inflammation predict later grip strength in HIV-infected men: The MACS Body Composition Substudy.AIDS Res Hum Retroviruses2013; 29: 1138–1145.
12.
KamogawaK., KoharaK., TabaraY.Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study.Dement Geriatr Cogn Disord2010; 30: 432–439.
13.
AnanF., MasakiT., ShimomuraT.Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus.Neuroimage2010; 49: 57–62.
14.
SartoriA.C., VanceD.E., SlaterL.Z., CroweM.The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research.J Neurosci Nurs2012; 44: 206–217.
15.
CraftS., FosterT.C., LandfieldP.W., MaierS.F., ResnickS.M., YaffeK.Session III: mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes.J Gerontol A Biol Sci Med Sci2012; 67: 754–759.
16.
MynarcikD.C., McNurlanM.A., SteigbigelR.T., FuhrerJ., GelatoM.C.Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.J Acquir Immune Defic Syndr2000; 25: 312–321.
17.
SamarasK., GanS.K., PeakeP.W., CarrA., CampbellL.V.Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection.Obesity (Silver Spring)2009; 17: 53–59.
18.
LiebW., BeiserA.S., VasanR.S.Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.JAMA2009; 302: 2565–2572.
19.
JungT.W., LeeJ.Y., ShimW.S.Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.Biochem Biophys Res Commun2006; 343: 564–570.
20.
JeonB.T., ShinH.J., KimJ.B.Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity.Brain Res Rev2009; 61: 81–88.
21.
DebetteS., BeiserA., HoffmannU.Visceral fat is associated with lower brain volume in healthy middle-aged adults.Ann Neurol2010; 68: 136–144.
22.
ParuthiJ., GillN., MantzorosC.S.Adipokines in the HIV/ HAART-associated lipodystrophy syndrome.Metabolism2013; 62: 1199–1205.
23.
KaslowR.A., OstrowD.G., DetelsR., PhairJ.P., PolkB.F., RinaldoC.R.Jr.. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.Am J Epidemiol1987; 126: 310–318.
24.
MillerE.N., SelnesO.A., McArthurJ.C.Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS).Neurology1990; 40: 197–203.
25.
HaciogluY., GuptaM., ChoiT.Y.Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy.Anadolu Kardiyol Derg2013; 13: 207–214.
26.
PostW.S., BudoffM., KingsleyL.Associations between HIV infection and subclinical coronary atherosclerosis.Ann Intern Med2014; 160: 458–467.
27.
BondarR.J., MeadD.C.Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum.Clin Chem1974; 20: 586–590.
28.
HultinL.E., MenendezF.A., HultinP.M.Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods.Cytometry B Clin Cytom2007; 72: 249–255.
29.
MooijaartS.P., SattarN., TrompetS.Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.J Intern Med2013; 274: 77–85.
30.
MarioniR.E., StrachanM.W., ReynoldsR.M.Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Diabetes2010; 59: 710–713.
31.
SchramM.T., EuserS.M., de CraenA.J.Systemic markers of inflammation and cognitive decline in old age.J Am Geriatr Soc2007; 55: 708–716.
32.
McDonaldB., MoyoS., GabaitiriL.Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.AIDS Res Hum Retroviruses2013; 29: 993–999.
33.
CrawfordK.W., LiX., XuX.Lipodystrophy and inflammation predict later grip strength in HIV-infected men: The MACS Body Composition Substudy.AIDS Res Hum Retroviruses2013; 29: 1138–1145.
34.
DuprezD.A., NeuhausJ., KullerL.H.Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.PLoS ONE2012; 7: e44454.
35.
KullerL.H., TracyR., BellosoW.Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.PLoS Med2008; 5: e203.
36.
DuncanB.B., SchmidtM.I., PankowJ.S.Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.Diabetes2004; 53: 2473–2478.
37.
VegaG.L., GrundyS.M.Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio.J Obes2013; 2013: 409679.
38.
KetlogetsweK.S., PostW.S., LiX.Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.AIDS2014; 28: 901–909.
TomizawaA., HattoriY., KasaiK., NakanoY.Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs high molecular weight adiponectin.Diab Vasc Dis Res2008; 5: 123–127.
41.
McArthurJ.C., HooverD.R., BacellarH.Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.Neurology1993; 43: 2245–2252.
42.
GrimaP.F., MassimilianoF., MondiA.High grade liver steatosis and cognitive impairment in HIV+ patients.20th Conference on Retroviruses and Opportunistic Infections. 3–5 March 2013, Atlanta, GA, USA. Abstract 552.
43.
Gallego-EscuredoJ.M., Del Mar GutierrezM., Diaz-DelfinJ.Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines.Curr HIV Res2010; 8: 545–553.
44.
LagathuC., EustaceB., ProtM.Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.Antivir Ther2007; 12: 489–500.
45.
De LucaA., de Gaetano DonatiK., Cozzi-LepriA.Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.J Acquir Immune Defic Syndr2012; 60: e98–e101.
46.
PadillaS., MasiaM., GarciaN., JarrinI., TormoC., GutierrezF.Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir.BMC Infect Dis2011; 11: 40.
47.
PalellaF.J.Jr., GangeS.J., BenningL.Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.AIDS2010; 24: 1657–1665.
